PLSE
Price
$53.11
Change
-$1.32 (-2.43%)
Updated
Sep 11 closing price
Capitalization
3.79B
65 days until earnings call
Intraday BUY SELL Signals
SRTS
Price
$3.15
Change
+$0.03 (+0.96%)
Updated
Sep 11 closing price
Capitalization
51.86M
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PLSE vs SRTS

PLSE vs SRTS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
PLSE vs. SRTS commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLSE is a Hold and SRTS is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLSE($3.79B) has a higher market cap than SRTS($51.9M). PLSE YTD gains are higher at: 286.817 vs. SRTS (-20.854). SRTS has higher annual earnings (EBITDA): -12.63M vs. PLSE (-82.02M). PLSE has more cash in the bank: 102M vs. SRTS (15.2M). SRTS has less debt than PLSE: SRTS (343K) vs PLSE (6.77M). SRTS has higher revenues than PLSE: SRTS (17.5M) vs PLSE (1.19M).
PLSESRTSPLSE / SRTS
Capitalization3.79B51.9M7,299%
EBITDA-82.02M-12.63M650%
Gain YTD286.817-20.854-1,375%
P/E RatioN/A31.50-
Revenue1.19M17.5M7%
Total Cash102M15.2M671%
Total Debt6.77M343K1,974%
FUNDAMENTALS RATINGS
PLSE vs SRTS: Fundamental Ratings
PLSE
SRTS
OUTLOOK RATING
1..100
9192
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
40100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
3454
P/E GROWTH RATING
1..100
10014
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SRTS's Valuation (67) in the Medical Specialties industry is in the same range as PLSE (94). This means that SRTS’s stock grew similarly to PLSE’s over the last 12 months.

PLSE's Profit vs Risk Rating (40) in the Medical Specialties industry is somewhat better than the same rating for SRTS (100). This means that PLSE’s stock grew somewhat faster than SRTS’s over the last 12 months.

SRTS's SMR Rating (97) in the Medical Specialties industry is in the same range as PLSE (98). This means that SRTS’s stock grew similarly to PLSE’s over the last 12 months.

PLSE's Price Growth Rating (34) in the Medical Specialties industry is in the same range as SRTS (54). This means that PLSE’s stock grew similarly to SRTS’s over the last 12 months.

SRTS's P/E Growth Rating (14) in the Medical Specialties industry is significantly better than the same rating for PLSE (100). This means that SRTS’s stock grew significantly faster than PLSE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PLSESRTS
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 13 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 4 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (PLSE: $53.11 vs. SRTS: $3.15)
Brand notoriety: PLSE and SRTS are both not notable
PLSE represents the Pharmaceuticals: Other, while SRTS is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: PLSE: 136% vs. SRTS: 34%
Market capitalization -- PLSE: $3.79B vs. SRTS: $51.86M
PLSE [@Pharmaceuticals: Other] is valued at $3.79B. SRTS’s [@Medical/Nursing Services] market capitalization is $51.86M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $130.41B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $1.86K to $176.41B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.43B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLSE’s FA Score shows that 0 FA rating(s) are green while SRTS’s FA Score has 1 green FA rating(s).

  • PLSE’s FA Score: 0 green, 5 red.
  • SRTS’s FA Score: 1 green, 4 red.
According to our system of comparison, PLSE is a better buy in the long-term than SRTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLSE’s TA Score shows that 3 TA indicator(s) are bullish while SRTS’s TA Score has 3 bullish TA indicator(s).

  • PLSE’s TA Score: 3 bullish, 5 bearish.
  • SRTS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both PLSE and SRTS are a bad buy in the short-term.

Price Growth

PLSE (@Pharmaceuticals: Other) experienced а -0.24% price change this week, while SRTS (@Medical/Nursing Services) price change was -1.25% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.51%. For the same industry, the average monthly price growth was -3.46%, and the average quarterly price growth was +12.67%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.01%. For the same industry, the average monthly price growth was -8.95%, and the average quarterly price growth was -6.66%.

Reported Earning Dates

PLSE is expected to report earnings on Nov 16, 2026.

SRTS is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-5.01% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
PLSE
Daily Signal:
Gain/Loss:
SRTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SRORX15.150.15
+1.00%
Calamos Antetokounmpo Sustainable Eqs R6
CDHIX45.10N/A
N/A
Calvert International Responsible Idx I
ITHVX62.82N/A
N/A
Hartford Capital Appreciation R6
JRSDX12.62N/A
N/A
JH Adaptive Risk Mgd U.S. Eq D
SSIQX16.36N/A
N/A
State Street International Stock Sel K

PLSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLSE has been loosely correlated with NVST. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PLSE jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLSE
1D Price
Change %
PLSE100%
-2.43%
NVST - PLSE
39%
Loosely correlated
-1.24%
CERS - PLSE
38%
Loosely correlated
+1.22%
CLPT - PLSE
32%
Poorly correlated
+1.78%
ARAY - PLSE
32%
Poorly correlated
+2.96%
TMCI - PLSE
32%
Poorly correlated
+3.68%
More